Articles related to PARKINSON'S DISEASE (PD)

Deep brain stimulation offers a new avenue for Parkinson’s treatment but comes with its own set of lifestyle and medical considerations. Equip yourself with the knowledge to guide your patients through this transformative yet complex option.

Northwestern Medicine’s recent study uncovers a novel interaction between lysosomes and mitochondria, disrupted by mutations in the parkin gene, contributing to Parkinson’s disease. This discovery offers a new therapeutic pathway and emphasizes the significance of organelle communication in neurodegenerative disorders.

Explore the recent meta-analysis that delves into the potential of cholinesterase inhibitors in treating delusions and hallucinations in dementia patients. The findings reveal significant but clinically insignificant effects, highlighting the need for further research and targeted treatments.

Recent research suggests that precise deep brain stimulation could play a pivotal role in altering the progression of early-stage Parkinson’s disease. Take a look at the study’s findings and its implications for future treatments.

The recent 30-year study involving folate, vitamin B6, and B12 in relation to Parkinson’s disease risk provides inconclusive evidence for the vitamins’ protective role. Further research, considering various factors like supplementation and demographic characteristics, may elucidate any potential benefits in PD prevention.

Explore the new era of Parkinson’s disease treatment with the Cala kIQ System, a wearable, FDA-approved device designed to control action tremors by emulating the principles of deep brain stimulation.